اكتشف أفضل عيادات وتكاليف العلاج سرطان الرحم في إيطاليا 2024

الدكتورة جيورجيا مانغيلي هي رئيسة المجموعة الطبية لطب الأورام النسائية ، وحدة التوليد وأمراض النساء في مستشفى معهد سان رافاييل العلمي. تركز الدكتورة مانجيلي على عملها في طب الأورام النسائية ، وعلاج الأورام النسائية النادرة ، والحفاظ على الخصوبة في الأورام والسرطان والحمل. خبرة في العمل منذ عام 2002 - رئيس وحدة الأورام النسائية في قسم أمراض النساء والتوليد في IRCCS Ospedale San Raffaele 1992-2002 - مساعد طبي في قسم التوليد وأمراض النساء في IRCCS Ospedale San Raffaele. تعليم 1983 - كلية الطب بجامعة ميلانو - إجازة في الطب العام 1987 - كلية الطب بجامعة ميلانو - تخصص في أمراض النساء والتوليد 1991 - كلية الطب بجامعة ميلانو - بيكوكا - تخصص في علم الأورام 2013 - التأهيل لأستاذ مشارك في أمراض النساء والتوليد 2017 - التأهيل لأستاذ التوليد وأمراض النساء. النشاط العلمي مجلس إدارة المحاكمات الإيطالية متعددة المراكز في سرطان المبيض والأورام الخبيثة النسائية عضوية المنظمة الأوروبية لعلاج أمراض الأرومة الغاذية الجمعية الأوروبية لطب الأورام النسائية الجمعية الإيطالية لطب الأورام النسائية.

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).

Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities. He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.  In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.  Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.  Current Positions:  .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007. - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy. - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy. - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy). - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy). - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy). - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.   In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).      Publications: santoro%a - Search Results - PubMed (nih.gov)